Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer
Pulsenmore appointed medtech veteran David Woods as Chief Commercial Officer and is expanding its U.S. commercial team as it scales stateside operations. Woods brings 25+ years of medtech experience, most recently as CCO of Creo Medical and previously President and CEO of PENTAX Medical Americas.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.